Order Article Reprints

Saeed A, Ejaz SA, Sarfraz M, Tamam N, Siddique F, Riaz N, Qais FA, Chtita S, Iqbal J. Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer. Molecules. 2022; 27(13):3981. https://doi.org/10.3390/molecules27133981

Saeed, Amna, Syeda Abida Ejaz, Muhammad Sarfraz, Nissren Tamam, Farhan Siddique, Naheed Riaz, Faizan Abul Qais, Samir Chtita, and Jamshed Iqbal. 2022. "Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer" Molecules 27, no. 13: 3981. https://doi.org/10.3390/molecules27133981

Saeed, A., Ejaz, S. A., Sarfraz, M., Tamam, N., Siddique, F., Riaz, N., Qais, F. A., Chtita, S., & Iqbal, J. (2022). Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer. Molecules, 27(13), 3981. https://doi.org/10.3390/molecules27133981